TN2009000131A1 - Pegylated pth as pth receptor modulators and uses thereof - Google Patents

Pegylated pth as pth receptor modulators and uses thereof

Info

Publication number
TN2009000131A1
TN2009000131A1 TNP2009000131A TN2009000131A TN2009000131A1 TN 2009000131 A1 TN2009000131 A1 TN 2009000131A1 TN P2009000131 A TNP2009000131 A TN P2009000131A TN 2009000131 A TN2009000131 A TN 2009000131A TN 2009000131 A1 TN2009000131 A1 TN 2009000131A1
Authority
TN
Tunisia
Prior art keywords
pth
pegylated
receptor modulators
pth receptor
mammal
Prior art date
Application number
TNP2009000131A
Other languages
French (fr)
Inventor
Patricia Lea Brown-Augsburger
Wayne David Kohn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/080367 external-priority patent/WO2008048784A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2009000131A1 publication Critical patent/TN2009000131A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compositions and methods are provided for the treatment and prevention of bone loss diseases including osteoporosis in a mammal.
TNP2009000131A 2007-10-04 2009-04-08 Pegylated pth as pth receptor modulators and uses thereof TN2009000131A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/080367 WO2008048784A1 (en) 2006-10-13 2007-10-04 Pegylated pth as pth receptor modulators and uses thereof

Publications (1)

Publication Number Publication Date
TN2009000131A1 true TN2009000131A1 (en) 2010-10-18

Family

ID=42828674

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000131A TN2009000131A1 (en) 2007-10-04 2009-04-08 Pegylated pth as pth receptor modulators and uses thereof

Country Status (1)

Country Link
TN (1) TN2009000131A1 (en)

Similar Documents

Publication Publication Date Title
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
HK1144390A1 (en) Compositions for the treatment of neoplastic diseases
EP2056818A4 (en) Compositions and methods for neuroprotection
PH12013502192A1 (en) Antibodies against human angiopoietin 2
HUE041764T2 (en) Compositions suitable for treating collagen-mediated diseases
MX2012001974A (en) Biaryl compounds and methods of use thereof.
SG169353A1 (en) Tamper resistant dosage forms
EP2475358A4 (en) Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
IL193747A0 (en) New therapeutic combinations for the treatment of depression
MX2010006204A (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases.
EP2365815A4 (en) Extracellular matrix compositions for the treatment of cancer
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
IL198723A0 (en) Methods and compositions for therapeutic treatment
EP2217238A4 (en) Methods and compositions for the treatment of proteinuric diseases
MX2010006388A (en) Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists.
ZA200805761B (en) Pharmaceutical composition for the treatment of nail disease
SG153015A1 (en) Herbal medicine for osteoporosis and related conditions
MX2009003740A (en) Pegylated pth as pth receptor modulators and uses thereof.
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
TN2009000131A1 (en) Pegylated pth as pth receptor modulators and uses thereof
EP2344528A4 (en) Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof
CA2853804C (en) Anti-flush compositions
GB0621308D0 (en) An implement for administering medicine